Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 1.000 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.530 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.511 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.508 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.507 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.503 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.502 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.501 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.495 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.493 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.492 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.492 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.492 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.489 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.489 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.484 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.480 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.478 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.478 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.478 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.476 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.474 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.471 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.471 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.469 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.468 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.467 | |
3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.465 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.465 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.465 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.463 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
4f1s | F1S | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.460 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.459 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.459 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.458 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.451 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.450 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
4xhg | ADP | Uncharacterized protein | / | 0.450 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.449 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.448 | |
2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.447 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.447 | |
2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.447 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.447 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.447 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.447 | |
1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.446 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.445 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.445 | |
3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.445 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.444 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.444 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.443 | |
4j98 | ACP | Fibroblast growth factor receptor 2 | / | 0.443 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.443 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.442 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 |